1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Skin cancer

Pembrolizumab for adjuvant treatment of locally advanced cutaneous squamous cell carcinoma after surgery and radiotherapy ID 6473

In development [GID-TA11582] Expected publication date: TBC

Register as a stakeholder
  • Project information
  • Project documents

20578-Pembrolizumab-for-Cutaneous-Squamous-Cell-Carcinoma-V1.0-MAY2024-NON-CONF.pdf (nihr.ac.uk)